Grants
Federal funding opportunities from Grants.gov — still-open first, soonest deadline at the top.
FDA ▾
Expanding the Opioids System Model to more comprehensively incorporate fentanyl, stimulants use, polysubstance use and associated outcomes.
Development of a model selection method for population pharmacokinetics analysis by deep-learning based reinforcement learning
Drug Development Tools Research Grants (U01 Clinical Trial Optional)
Minor Use Minor Species Development of Drugs (R01) Clinical Trials Not Allowed
Enhancing Innovations in Advanced Manufacturing Technologies for Vaccines against Influenza and Emerging Infectious Diseases
AAV Vector manufacturing for diseases affecting very small populations
Integrated Pathogen Reduction Technologies for whole blood and blood components for transfusion (R01) Clinical Trials Not Allowed
Pediatric and Perinatal COVID-19 Registry (U18) Clinical Trials Optional
SmartTots (Strategies for Mitigating Anesthesia-Related neuroToxicity in Tots) Public-Private Partnership (PPP) under PASI (Pediatric Anesthesia Safety Initiative) (U01) Clinical Trials Not Allowed
Collaboration in Regulatory Systems Strengthening and Standardization Activities to Increase Global Access to Safe and Effective Biological Products (U01) Clinical Trials Not Allowed
AAV Vector manufacturing for diseases affecting very small populations (R01) Clinical Trials Not Allowed
Strategies that Support Global Food Safety (U01) Clinical Trial Not Allowed